Do non-adrenergic vasopressors improve survival in patients with or at risk for vasodilatory shock?
Non-adrenergic vasopressors may improve survival in patients with or at risk for vasodilatory shock, though further research is needed to confirm this finding.
Catecholamine-sparing agents in patients with or at risk for vasodilatory shock may improve survival. Further researches on this topic are needed to confirm the finding.
Belletti et al. (Wed,) studied this question.